GHRH(1-29) Analog
Sermorelin
Synthetic GHRH(1-29) fragment studied for pituitary GH secretion, IGF-1 modulation, and growth hormone axis research in preclinical models.
Select Size
Tested by: SGS Life Sciences · Batch: VRC-SRM-2406 · Jun 2026
About Sermorelin
Sermorelin (GHRH 1-29 NH₂) is a synthetic peptide corresponding to the first 29 amino acids of endogenous growth hormone-releasing hormone, representing the shortest fully active fragment. It stimulates the pituitary gland to produce and secrete GH in a physiological, pulsatile manner. Preclinical and clinical research has studied its role in GH deficiency models, IGF-1 elevation, and age-related GH decline. It is used as a reference GHRH agonist in growth hormone axis research.
Research Areas
Technical Specifications
Molecular Weight
3357.93 g/mol
Amino Acid Sequence
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
Storage
Lyophilized: −20°C, stable 24 months. Reconstituted: 4°C, use within 28 days.
Solubility
Soluble in sterile water at ≥1 mg/mL
For Research Purposes Only. Sermorelin is sold exclusively for in vitro laboratory research. Not for human consumption, diagnostic, therapeutic, or veterinary use. See our Research Use Disclaimer.